Literature DB >> 16481365

Profiling risk: the emergence of coronary heart disease epidemiology in the United States (1947-70).

Gerald M Oppenheimer1.   

Abstract

This historical study examines the development of coronary heart disease (CHD) research and its role in the evolution of post-1945 chronic disease epidemiology in the United States. To give the examination greater salience, it compares the pathway represented by CHD epidemiology with that of lung cancer. Historians have paid less attention to the differences between the two, which later merged into what we now call 'risk factor epidemiology'. This study assesses why CHD epidemiology in the post-war period almost uniformly began with cohort studies and primarily stressed clinical variables as putative aetiological factors. It describes how CHD epidemiologists sought to justify the creation of a non-infectious chronic disease epidemiology, a position reinforced by the relative swiftness with which they obtained important results. It also follows the emergence of 'risk factor thinking' within CHD epidemiology. CHD epidemiology critically differed from its lung cancer counterpart in that it identified multiple factors of risk, each producing relatively small effects, rather than a single factor producing a strong and evident outcome. Consequently, it was difficult for CHD epidemiologists to demonstrate causality and to confirm scientifically that reducing risk factors would lower CHD rates. This had significant consequences for primary prevention and public health policy.

Entities:  

Mesh:

Year:  2006        PMID: 16481365     DOI: 10.1093/ije/dyl014

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

1.  Methods and management: NIH administrators, federal oversight, and the Framingham Heart Study.

Authors:  Sejal S Patel
Journal:  Bull Hist Med       Date:  2012       Impact factor: 1.314

2.  The Origins and Early Evolution of Epidemiologic Research in Cardiovascular Diseases: A Tabular Record of Cohort and Case-Control Studies and Preventive Trials Initiated From 1946 to 1976.

Authors:  Henry Blackburn
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

3.  Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case control study: a case-control study.

Authors:  Guo-Hua Zheng; Shang-Quan Xiong; Li-Juan Mei; Hai-Ying Chen; Ting Wang; Jian-Feng Chu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Historicising "containment and delay": COVID-19, the NHS and high-risk patients.

Authors:  Martin D Moore
Journal:  Wellcome Open Res       Date:  2020-06-10

5.  Social disorder and diagnostic order: the US Mental Hygiene Movement, the Midtown Manhattan study and the development of psychiatric epidemiology in the 20th century.

Authors:  Dana March; Gerald M Oppenheimer
Journal:  Int J Epidemiol       Date:  2014-07-15       Impact factor: 7.196

Review 6.  The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Authors:  Syed S Mahmood; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Lancet       Date:  2013-09-29       Impact factor: 79.321

7.  A genealogy of epidemiological reason: Saving lives, social surveys and global population.

Authors:  David Reubi
Journal:  Biosocieties       Date:  2017-07-03

Review 8.  How did social medicine evolve, and where is it heading?

Authors:  Dorothy Porter
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

9.  Society as Cause and Cure: The Norms of Transgender Social Medicine.

Authors:  Ketil Slagstad
Journal:  Cult Med Psychiatry       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.